174 related articles for article (PubMed ID: 15668280)
1. Development of axillary surgery in breast cancer.
Luini A; Gatti G; Ballardini B; Zurrida S; Galimberti V; Veronesi P; Vento AR; Monti S; Viale G; Paganelli G; Veronesi U
Ann Oncol; 2005 Feb; 16(2):259-62. PubMed ID: 15668280
[TBL] [Abstract][Full Text] [Related]
2. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
[TBL] [Abstract][Full Text] [Related]
3. Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy.
Jansen L; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Peterse JL; de Vries J; Doting MH; Kroon BB
Eur J Surg Oncol; 1998 Oct; 24(5):445-6. PubMed ID: 9800978
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.
Veronesi U; Paganelli G; Viale G; Galimberti V; Luini A; Zurrida S; Robertson C; Sacchini V; Veronesi P; Orvieto E; De Cicco C; Intra M; Tosi G; Scarpa D
J Natl Cancer Inst; 1999 Feb; 91(4):368-73. PubMed ID: 10050871
[TBL] [Abstract][Full Text] [Related]
5. Role of axillary sampling in the era of sentinel lymph node biopsy: a critical review.
Bassi KK; Seenu V; Srivastava A; Al Sharara N
Indian J Cancer; 2012; 49(1):66-73. PubMed ID: 22842171
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer.
Hsueh EC; Hansen N; Giuliano AE
CA Cancer J Clin; 2000; 50(5):279-91. PubMed ID: 11075238
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
8. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
9. A comparison of rates of lymph node metastases between patients undergoing sentinel and axillary lymphadenectomy.
Moonka R; Hunter JA; Cray WK; Duncan M; Wechter DG
Am J Surg; 2002 May; 183(5):558-61. PubMed ID: 12034393
[TBL] [Abstract][Full Text] [Related]
10. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
[TBL] [Abstract][Full Text] [Related]
11. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
12. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
13. [Sentinel lymph node status and axillary lymph node dissection in the surgical treatment of breast cancer].
Cserni G
Orv Hetil; 2014 Feb; 155(6):203-15. PubMed ID: 24486844
[TBL] [Abstract][Full Text] [Related]
14. [Preoperative Axillary Lymph Node Marking in Patients with Breast Cancer].
Dostálek L; Šašková P
Klin Onkol; 2017; 30(6):420-425. PubMed ID: 29271212
[TBL] [Abstract][Full Text] [Related]
15. [Strategies for management of axillary lymph nodes in breast cancer. Point of view of the Institut Bergonié. ].
de Mascarel I; MacGrogan G
Ann Pathol; 2003 Dec; 23(6):518-33. PubMed ID: 15094590
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
17. Radical axillary dissection in sentinel lymph node biopsy era: it's still a considerable technique in breast cancer management?
Sanguinetti A; Catania A; Docimo G; Avenia N
G Chir; 2010; 31(6-7):344-6. PubMed ID: 20646390
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
19. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
20. Axillary dissection over the years: where to from here?
Keshtgar MR; Baum M
World J Surg; 2001 Jun; 25(6):761-6. PubMed ID: 11376413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
